Nuclera is a pioneering company specializing in rapid protein prototyping technology, aimed at accelerating drug discovery. Their flagship product, eProtein Discovery™, offers an end-to-end solution for designing, expressing, and purifying proteins, allowing researchers to synthesize proteins on demand. With capabilities like screening multiple constructs and obtaining various protein variations, Nuclera's technology empowers scientists to explore proteins faster and more efficiently, significantly reducing the time required for drug development processes.